Poulami Samai

Regeneron Pharmaceuticals Inc - Warsaw / United States

Natural Sciences / Molecular Biology & Genetics

AD Scientific Index ID: 4417613

-

Go Premium -
Unlock Full Profile Tools

Get Your Global Impact Certificate

Regeneron Pharmaceuticals Inc

Poulami Samai's MOST POPULAR ARTICLES

1-) Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system Nucleic acids research 41 (15), 7429-7437, 2013

2-) Cas9 specifies functional viral targets during CRISPR–Cas adaptation Nature 519 (7542), 199, 2015

3-) Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity Cell 161 (5), 1164-1174, 2015

4-) Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity Cell 164 (4), 710-721, 2016

5-) Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system Journal of bacteriology 196 (2), 310-317, 2014

ARTICLES

Add your articles